Travel & financial grants

The Assistance Fund

The Assistance Fund's Hemophilia Financial Assistance Program helps patients with out-of-pocket costs such as prescription drugs, health insurance premiums, therapy administration, ground travel to treatment centers, and genetic testing. To qualify, patients must be a U.S. citizen or permanent resident, diagnosed with Hemophilia, prescribed an FDA-approved treatment, have prescription coverage, and meet financial eligibility criteria based on household income and size. The program is currently accepting waitlist applications.

The Assistance Fund

The Assistance Fund: Lupus program provides financial support for U.S. citizens or permanent residents diagnosed with lupus who are prescribed specific FDA-approved treatments. It helps cover copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses. Eligibility is determined by household income and size, and applicants must have commercial insurance, Medicare, or Medicaid.

The Assistance Fund

The Assistance Fund: Non-Small Cell Lung Cancer (NSCLC) program provides needs-based financial assistance for copays, coinsurance, and deductibles for FDA-approved NSCLC treatments. It is available to commercially insured, Medicare/Medicaid, underinsured, and uninsured residents of the US and Puerto Rico. While the main program is currently not funded, a waitlist option for future assistance is available.

The Assistance Fund

The Assistance Fund: Thyroid Cancer: Waitlist program provides financial support for FDA-approved thyroid cancer treatments, covering copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses. It is available to commercially insured, Medicare, or Medicaid patients residing in the US and Puerto Rico who demonstrate financial need.

The Assistance Fund

The Assistance Fund: Non-Small Cell Lung Cancer (NSCLC) program provides financial assistance for copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses for FDA-approved NSCLC treatments. It is available to commercially insured, Medicare/Medicaid patients residing in the US and Puerto Rico, and is needs-based.

CancerCare

Sanofi Genzyme

The Caprelsa Access Support program is not a travel assistance grant. It provides financial assistance for the CAPRELSA medication itself, including copay support for eligible commercially insured patients and patient assistance for uninsured or underinsured individuals. The program helps patients manage the cost of their CAPRELSA treatment.

AstraZeneca

CAPRELSA Patient Access Services (CPAS) is a program developed by AstraZeneca. Its purpose is to assess patients’ insurance coverage and direct them to appropriate sources for financial assistance for which they may be eligible. The service acts as a referral point rather than directly providing specific types of assistance.

HealthWell Foundation

This HealthWell Foundation grant assists Medicare patients with prescription drug copays or Medicare Part B insurance premiums for Chemotherapy Induced Neutropenia. Eligibility requires treatment in the U.S., Medicare coverage, and a household income up to 500% of the Federal Poverty Level. The fund is currently closed to new patients.

Minnesota Department of Human Services

Genentech

Gamifant Cares is listed as a patient access program likely offered by Genentech. However, this page provides no specific details regarding what the grant covers, who qualifies, or how to apply. No information on income requirements, max grant amount, or travel distance is available.

HealthWell Foundation

This HealthWell Foundation grant offers financial assistance for prescription drug copays or Medicare Part B insurance premiums for individuals being treated for Carcinoid Tumors and Associated Symptoms. Eligibility requires patients to be receiving treatment in the United States, have Medicare, and have a household income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living.

HealthWell Foundation

This HealthWell Foundation grant assists Medicare patients with chemotherapy-induced neutropenia by covering prescription drug copays or Medicare Part B insurance premiums, up to a maximum of $3,500. Eligibility requires treatment in the U.S. and a household income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living areas.

HealthWell Foundation

This HealthWell Foundation grant provides assistance for prescription drug copays or Medicare Part B insurance premiums for individuals being treated for Chronic Lymphocytic Leukemia, with a maximum award level of $8,000. To qualify, applicants must receive treatment in the U.S., have insurance covering their medication (Medicare Part B for premium assistance), and have a household income up to 500% of the Federal Poverty Level.

HealthWell Foundation

The HealthWell Foundation offers copayment and premium assistance for immunosuppressive treatments like Astagraf XL and Tacrolimus, with an annual maximum benefit of $1200. This program is for Medicare patients who are U.S. or Puerto Rico residents and have undergone a solid organ transplant, requiring applicants to demonstrate financial need.

HealthWell Foundation

The HealthWell Foundation Cytomegalovirus Disease - Prevention and Treatment program offers financial assistance for individuals undergoing treatment for Cytomegalovirus Disease. It covers co-pays and premiums for crucial medications, including off-label drugs. Eligible patients must be residents of the US or Puerto Rico, have commercial, Medicare, or Medicaid insurance, and meet specific financial need requirements.

HealthWell Foundation

HealthWell Foundation

This HealthWell Foundation grant provides financial assistance for prescription drug copays or Medicare Part B insurance premiums for individuals undergoing treatment for ovarian cancer, with a maximum award of $3,500. To qualify, applicants must have Medicare, be treated for Ovarian Cancer in the U.S., and meet household income guidelines up to 500% of the Federal Poverty Level (adjusted). Please note that this fund is currently closed to new patients due to insufficient funding.

HealthWell Foundation

The HealthWell: Prostate Cancer - Medicare Access program provides needs-based financial support, up to $6000 annually, for US and Puerto Rico residents under Medicare to help cover co-pays or premiums for prostate cancer drugs. However, the program is currently not funded and thus not accepting applications.

HealthWell Foundation

HealthWell Foundation

HealthWell Foundation

HealthWell Foundation

This fund, currently closed to new patients, offers assistance for prescription drug copays or Medicare Part B insurance premiums for individuals diagnosed with Urea Cycle Disorders. To qualify, applicants must have health insurance, receive treatment in the United States, and have a household income up to 500% of the Federal Poverty Level.

HealthWell Foundation

HealthWell Foundation

The HealthWell: Huntington's Disease - Medicare Access program provides financial assistance for medication copayments and premiums to eligible patients with Huntington's Disease. It is open to US and Puerto Rico residents with Medicare, and eligibility is needs-based. This fund is currently not accepting applications as it is 'Not Funded'.

HealthWell Foundation

Johnson & Johnson

Johnson & Johnson

The provided page content is a raw PDF stream and cannot be parsed to extract information about the grant's coverage or eligibility requirements. Therefore, details about what the grant covers and who qualifies are unknown.

National Kidney Foundation of Florida

Due to the unreadable nature of the provided page content, it is not possible to determine the specific coverage types or eligibility requirements for the National Kidney Foundation of Florida Patient Assistance Program. Further information is needed to describe what the grant covers and who qualifies.

Novartis Pharmaceuticals Corporation

The Novartis Patient Support (COSENTYX Connect) program offers co-pay assistance for privately insured patients taking COSENTYX, aiming for $0 out-of-pocket costs if eligible. It also provides free medication for up to two years for eligible privately insured patients whose initial coverage is denied, while working to secure insurance approval. Eligibility excludes patients covered by federal or state programs like Medicare or Medicaid.

HealthWell Foundation

This grant from HealthWell Foundation provides assistance with prescription drug copays or Medicare Part B insurance premiums for patients receiving treatment for ovarian cancer in the United States. Eligible applicants must have Medicare and an income up to 500% of the Federal Poverty Level, adjusted for household size and cost of living. The fund is currently closed to new patients due to lack of sufficient funding.

HealthWell Foundation

This HealthWell Foundation grant, currently closed to new patients, offers financial assistance for prescription drug copays or Medicare Part B insurance premiums for individuals with Ovarian Cancer. Eligible applicants must be receiving treatment in the U.S., have Medicare, and have a household income up to 500% of the Federal Poverty Level, adjusted for household size and high cost of living.

PAN Foundation

Patient Access Network Foundation

The PAN: Sickle Cell Disease (Medicare) program offers up to a $2000 annual benefit for medications to patients with sickle cell disease who have Medicare/Medicaid and reside in the US or Puerto Rico. It is a needs-based program, but it is currently not funded.

PAN Foundation

The PAN Foundation Transportation Fund offered grants of $500 to cover transportation expenses such as gas, parking, public transportation, taxis, and airfare. This fund is currently closed, and no specific eligibility requirements are detailed on this resource page.